Fig. 6.

The survival of hESC-derived DCL cells in Hu-mice. (a) Schematic description of the in vivo tracking of DCL cells. WT and CP DCL cells were labeled with CFDA and injected into the tail vein of Hu-mice. Two days, seven days and ten days after injection, the blood, spleen and thymus were collected and analyzed by flow cytometry for the presence of DCL cells. Hu-mice that didn`t receive any DCL cells were ered as controls. (b) The detection of WT and CP DCL cells in the spleen by flow cytometry. The data from the two groups were compared using the non-parametric Mann-Whitney test, * P<0.05. (c, d) The detection of WT and CP DCL cells in the blood (c) and (d) thymus by flow cytometry.